Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123395852 | 12339585 | 2 | F | 20160317 | 20160630 | 20160505 | 20160707 | EXP | US-AMGEN-USASP2016043610 | AMGEN | 68.00 | YR | E | M | Y | 71.20000 | KG | 20160707 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123395852 | 12339585 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Unknown | UNK | U | 103951 | UNKNOWN FORMULATION | ||||||||
123395852 | 12339585 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 20 MG, BID | AD2761Q | 0 | 20 | MG | BID | ||||||
123395852 | 12339585 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 85 MG/M2, Q2WK CYCLE | 0 | 85 | MG/M**2 | QOW | |||||||
123395852 | 12339585 | 4 | C | CAPECITABINE. | CAPECITABINE | 1 | UNK | 0 | |||||||||||
123395852 | 12339585 | 5 | C | XELOX | CAPECITABINEOXALIPLATIN | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123395852 | 12339585 | 1 | Product used for unknown indication |
123395852 | 12339585 | 2 | Myelofibrosis |
123395852 | 12339585 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123395852 | 12339585 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123395852 | 12339585 | Abdominal discomfort | |
123395852 | 12339585 | Abdominal distension | |
123395852 | 12339585 | Anaemia | |
123395852 | 12339585 | Arthralgia | |
123395852 | 12339585 | Asthenia | |
123395852 | 12339585 | Balance disorder | |
123395852 | 12339585 | Colorectal cancer | |
123395852 | 12339585 | Decreased appetite | |
123395852 | 12339585 | Dyspnoea | |
123395852 | 12339585 | Early satiety | |
123395852 | 12339585 | Fatigue | |
123395852 | 12339585 | Feeling abnormal | |
123395852 | 12339585 | Gait disturbance | |
123395852 | 12339585 | Headache | |
123395852 | 12339585 | Hepatomegaly | |
123395852 | 12339585 | Hyperhidrosis | |
123395852 | 12339585 | Nausea | |
123395852 | 12339585 | Neuropathy peripheral | |
123395852 | 12339585 | Night sweats | |
123395852 | 12339585 | Oedema peripheral | |
123395852 | 12339585 | Pain | |
123395852 | 12339585 | Peripheral coldness | |
123395852 | 12339585 | Therapeutic response unexpected | |
123395852 | 12339585 | Weight decreased | |
123395852 | 12339585 | White blood cell count decreased | |
123395852 | 12339585 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123395852 | 12339585 | 2 | 20160205 | 0 | ||
123395852 | 12339585 | 3 | 20160415 | 0 | ||
123395852 | 12339585 | 5 | 201603 | 0 |